CE: Summary of 2016 CHEST Guidelines

Emily Doycich


This review highlights the changes in recommended therapy, made by the American College of Chest Physicians in February 2016, for the treatment of venous thromboembolism disease. The data behind these recommendations has been evaluated to provide health care professionals with a more in-depth understanding of the treatment options available for their patients. This review discusses several gaps in the literature for health care professionals to note, as these are areas for further elucidation in the treatment of venous thromboembolism disease. 

Full Text:



  • There are currently no refbacks.

Notice and Disclaimer

Medicine is an ever-changing science.  As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required.  The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.  However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work.    Readers are encouraged to confirm the information contained herein with other sources.   For example and in particular, readers are advised to check the product information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.